Sukumar Nagendran

Taysha Gene Therapies Replaces CEO, Appoints R&D Chief

by | Dec 19, 2022

Dallas-based Taysha Gene Therapies is starting a new chapter in its fight to tackle devastating neurological conditions with changes in its top executive leadership.

Late Friday, the publicly traded biotech announced that Sean P. Nolan, the current chair of the board of directors and an experienced biopharmaceutical industry leader, is the company’s new CEO....

MORE